Mirae Asset Global ETFs Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.2M	Buy	156,809 +85,298	+119%	+$2.12M	0.01%	845
2026 Q1	$1.48M	Buy	71,511 +5,336	+8%	+$120K	﹤0.01%	1327
2025 Q4	$1.52M	Buy	66,175 +3,572	+6%	+$117K	﹤0.01%	1292
2025 Q3	$1.89M	Buy	62,603 +2,348	+4%	+$70.4K	﹤0.01%	1167
2025 Q2	$2.19M	Sell	60,255 -1,523	-2%	-$54.9K	﹤0.01%	1051
2025 Q1	$2.24M	Sell	61,778 -3,956	-6%	-$165K	﹤0.01%	1068
2024 Q4	$2.77M	Sell	65,734 -6,379	-9%	-$316K	0.01%	964
2024 Q3	$4.01M	Sell	72,113 -20,711	-22%	-$1.06M	0.01%	837
2024 Q2	$3.82M	Buy	+92,824	New	+$3.96M	0.01%	833

Other funds holding RARE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RARE Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Ultragenyx Pharmaceutical (RARE) stake by 119% in Q2 2026, buying an estimated $2.12M and bringing the position to 156,809 shares worth $5.2M. The position accounts for 0.01% of the portfolio, ranked #845.

Mirae Asset Global ETFs Holdings first reported a position in RARE in Q2 2024 and has held it in 9 quarters since. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

Mirae Asset Global ETFs Holdings held 156,809 shares of Ultragenyx Pharmaceutical worth $5.2M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 85,298 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $2.12M.
Ultragenyx Pharmaceutical made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #845 holding.
Mirae Asset Global ETFs Holdings first reported a position in Ultragenyx Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.